Explore how green chemistry can recover by shifting from a fragile business model to one focused on supply chain resilience and strategic differentiation.
What the Down Cycle Exposed -
The sustainability premium in chemicals collapsed faster than most boards saw coming.
Post-COVID, there was still real euphoria. Investors paid up for green. Boards made bold public commitments — circularity targets, bio-based feedstock pledges, low-carbon process investments. The story was irresistible: do the right thing and the market rewards you.
The down cycle exposed the premise. Margins compressed, capital got scarce, and almost no customer was willing to pay more for bio-based or low-carbon material. The valuation premium for green disappeared. And a wave of sustainability commitments got quietly recalibrated.
What the downturn revealed wasn't that green chemistry is wrong. It was that the business model underneath it was fragile — it depended on a market premium that the market never actually produced.
Then the Strait of Hormuz closed.
The Risk Frame That Actually Lands
Something changed in the conversation when the supply disruption hit. Not the sustainability conversation. A different one.
If your feedstock is sustainably derived rather than naphtha from a Gulf complex, you are not exposed to the Strait of Hormuz. If your packaging shifts from virgin polyethylene to paper — sourced from local wood fiber and recycled pulp — you are not exposed to the Strait of Hormuz. That’s not an ESG argument. That’s a supply chain resilience argument. And those land in entirely different places in a capital allocation conversation.
The insight is straightforward: bio-based and circular feedstocks carry a geographic hedge that fossil-based feedstocks don’t. Sustainably derived polymers, locally sourced wood fiber and recycled pulp — these don’t flow through contested maritime chokepoints. Four supply shocks in six years have given that observation real financial weight.
This reframe doesn’t replace the environmental case for circularity. It puts the business case on a foundation that doesn’t require customers to voluntarily pay more for green. They don’t — and they won’t. But they, and their CFOs, and their boards, do care about the supply chain exposure that just showed up in real margin damage.
Actioning the Insight
If you have bio-based or circular products in your portfolio, the window to move is open now — not in the post-crisis planning sense, but urgently. Procurement offices are acutely aware of what geopolitical supply disruption actually costs. That awareness creates commercial openings that didn’t exist six months ago.
Use them. Get into specifications. Lock in relationships. Build the application development that makes your product genuinely differentiated — not just an alternative, but the better solution.
The harder strategic question is what comes after: how do you hold that position when the Strait reopens?
It will reopen. Trough conditions will return. The sense of urgency in procurement fades, the economics of virgin petrochemicals recover, and the customer who was leaning toward bio-based polymers or paper packaging during the crisis starts fielding calls from competitors with lower prices on virgin poly.
The companies that turn this window into durable position aren’t the ones that let the resilience argument do all the work. They use the crisis-driven opening to build switching costs — technical integration, specification lock-in, application knowledge that the customer can’t easily replicate with a commodity alternative. Bio-based polymers that perform at spec and source locally can hold a position. Paper packaging from local wood and recycled pulp holds it better still, if the application development is done right.
The window is open. But the window isn’t the strategy. What you build inside it is.
Until next week,
Kendall -
Find me on LinkedIn or Book a 1:1 call
Not a subscriber yet? Subscribe here
